The MHRA will host a comprehensive webinar on September 5, 2025, addressing the evolving regulatory landscape in the UK following Brexit and the opportunities for pharmaceutical innovation.

Webinar Focus Areas

The session will cover key aspects of the UK's independent regulatory framework:

• UK regulatory pathway advantages and opportunities
• Post-Brexit approval timelines and processes
• International cooperation and mutual recognition agreements
• UK-specific guidance documents and requirements
• Northern Ireland Protocol implications

Innovation-Friendly Regulatory Approaches

The webinar will highlight the UK's commitment to regulatory innovation:

• Accelerated assessment pathways for breakthrough therapies
• Innovative licensing and approval procedures (ILAP)
• Early access to medicines scheme (EAMS) updates
• Digital-first regulatory submissions
• Real-world evidence integration strategies